EARLY RHEUMATOID ARTHRITIS: DIAGNOSIS AND TREATMENT ALGORITHMS


如何引用文章

全文:

详细

The review is dedicated to the problems of diagnosis and treatment of early rheumatoid arthritis (RA). Some new diagnostic criteria for RA (ACR/EULAR, 2010), recommendations for the management of patients with early arthritis, and basic principles of therapy of this disease by synthetic disease-modifying anti-rheumatic drugs and biologics are presented. It is emphasized that basic therapy is most effective in the early stage of RA, especially the first 3 months of the onset of the disease. The basis of management of patients with early RA is the close monitoring of the adequacy of the treatment (at least 1 time in 3 months) with subsequent correction of treatment, if necessary.

参考

  1. Ревматология: клинические рекомендации / Под ред. РАМН Е.Л. Насонова. М., 2011. С. 90-230
  2. Symmons D, Tricker K, Roberts C, Et al. The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis. Health Technol Assess 2005;9(34):1-78.
  3. Фоломеева О.М., Галушко Е.А., Эрдес Ш.Ф. Распространенность ревматических заболеваний в популяции населения России и США // Научно-практическая ревматология 2008. № 4. C. 4-14.
  4. Scott DL, Symmons DP, Coulton BL, et al. Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet 1987;1(8542):1108-11.
  5. Sharp JT. Speculations on Why Early Treatment of Rheumatoid Arthritis Is Uniquely Effective. J Rheumatol 2008;35:2090-93.
  6. Vermeer M, Kuper H, Hoekstra M, et al. Implementation of a treat to target strategy in very early rheumatoid arthritis: Results of the DREAM remission induction cohort. Arthritis Rheum 2011;doi: 10.1002/art.30494.
  7. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum 1988;31:315-24.
  8. Мурадянц А.А. Ранний ревматоидный артрит: клинико-лабораторные и инструментальные аспекты диагностики. Автореф. дис. на соиск. канд. мед.наук. Ярославль, 2000. C. 29.
  9. Каратеев Д.Е., Олюнин Е.Л., Лучихина Ю.А. Новые классификационные критерии ревматоидного артрита ACR/EULAR 2010 - шаг вперед к ранней диагностике // Научно-практическая ревматология 2011. № 1. C. 10-15.
  10. Corrao S, Calvo L, Licata G. The new criteria for classification of rheumatoid arthritis: what we need to know for clinical practice. Eur J Int Med 2011;22:217-19.
  11. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69:1580-88.
  12. Mjaavatten MD, Haugen AJ, Helgetveit K,. et al. Pattern of joint involvement and other disease characteristics of 364 patient with arthritis of less than 16 weeks duration. J Rheumatol 2009;36:1401-06.
  13. Scottish Intercollegiate Guidelines Network. Management of early rheumatoid arthritis. A national clinical guideline. Edinburgh: SIGN; 2011:27p. http://www.sign.ac.uk
  14. Combe B, Landewe R, Lukas C, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;66:34-45.
  15. Emery P, Breedveld FC, Dougados M, et al. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 2002;61(4):290-97.
  16. Kosta PE, Voulgari PV, Zikou AK, et al. The usefulness of magnetic resonance imaging of the hand and wrist in very early rheumatoid arthritis. Arth Res Ther 2011;13:R84doi: 10.1186/ar3355.
  17. Smolen JS, Aletaha D, Bijlsma JW, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69(4):631-37.
  18. Targeted treatment of the rheumatic diseases/ edited by M.H. Weisman,M.E. Weinblatt, J.S. Louie, R.F. van Vollenhoven: Published by W.B. Saunders Company 2009;1-45.
  19. Peris F, Bird HA, Serni U, et al. Treatment compliance and safety of aceclofenac versus standard NSAIDs in patients with common arthritic disorders: a meta-analysis. Eur J Rheumatol Inflamm 1996;16:37-45.
  20. Шостак Н.А. Ревматоидный артрит: современные подходы к лечению // Клиницист 2007. № 1. С. 4-12.
  21. Kuriya B, Arkema E, Bykerk V, et al. Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthiritis: a meta-analysis of clinical and radiographic remission. Ann Rheum Dis 2010;69(7):1298-1304.
  22. Katchamart W, Bourre-Tessier J, Donka T, et al. Canadian Recommendations for Use of Methotrexate in Patients with Rheumatoid Arthritis. J Rheumatol 2010;37(7):1422-30.
  23. Smolen JS, Landewe R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010;69:964-75.
  24. Saag K, Teng G, Patkar N, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying ant rheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008;59:762-84.
  25. Диагностика туберкулезной инфекции при планировании и проведении терапии блокаторами у больных ревматическими заболеваниями: Пособие для врачей. Ред. М.И. Перельман, Е.Л.Насонов. М., 2008. 40 с.
  26. Le Goff B, Berthelot JM, Maugars Y, et al. Alternative use of bisphosphonate therapy for rheumatic disease. Curr Pharm Des 2010;16(27):3045-52.
  27. Soejima M, Kawaguchi Y, Hara M. Therapeutic Effects of Alendronate on Bone Erosion and Atrophy in a Patient with RA and HCV Infection. J Rheumatol 2008;35:2284-85.
  28. Suzuki Y. Secondary osteoporosis. Bisphosphonates as a possible strategy for the prevention of bone destruction in rheumatoid arthritis. Clin Calcium 2007;17(12):1909-13.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2011
##common.cookie##